Company profile for ThermoGenesis

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

ThermoGenesis Holdings, Inc. develops, commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. The Company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress™ platform, which streamlines the manufacturing process for the emergi...
ThermoGenesis Holdings, Inc. develops, commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. The Company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress™ platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
2711 Citrus Road Rancho Cordova, CA 95742
Telephone
Telephone
(800) 783-8357
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

AMWC Asia-TDAC

AMWC Asia-TDAC

Not Confirmed

envelop Contact Supplier

AMWC Asia-TDAC

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/01/15/3010491/0/en/Biologic-Pharmamedical-Launches-Innovative-Functional-Beverages-for-Health-Longevity-and-Performance.html

GLOBENEWSWIRE
15 Jan 2025

https://www.contractpharma.com/contents/view_breaking-news/2023-03-15/thermogenesis-introduces-readystart-cgmp-suites-for-cgt-companies/?widget=listSection

CONTRACT PHARMA
15 Mar 2023

https://www.prnewswire.com/news-releases/thermogenesis-regains-compliance-with-nasdaq-minimum-bid-price-requirement-301718784.html

PR NEWSWIRE
11 Jan 2023

https://www.prnewswire.com/news-releases/thermogenesis-holdings-announces-financial-results-for-the-third-quarter-ended-september-30-2022-and-provides-corporate-update-301674988.html

PRNEWSWIRE
10 Nov 2022

https://www.prnewswire.com/news-releases/thermogenesis-prices-2-05-million-public-offering-301659300.html

PRNEWSWIRE
25 Oct 2022

https://www.prnewswire.com/news-releases/thermogenesis-awarded-nih-sbir-phase-i-grant-to-develop-key-cell-processing-disposable-for-quintessence-automated-manufacturing-of-gene-engineered-autologous-cell-geac-therapies-301376089.html

PRNEWSWIRE
14 Sep 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty